Renovacor, Inc.
(NYSE Amex Equities : RCOR)

( )
RCOR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
CCitigroup, Inc. 0.14%71.861.0%$1384.21m
LCIDLucid Group, Inc. -1.98%24.240.0%$948.68m
AXPAmerican Express Co. 1.28%179.581.7%$586.44m
RIOTRiot Blockchain, Inc. 1.98%31.440.0%$356.76m
GWHESS Tech, Inc. -8.33%15.730.0%$221.53m
PRUPrudential Financial, Inc. 1.89%114.031.5%$199.76m
DOCNDigitalOcean Holdings, Inc. -1.41%90.370.0%$169.89m
JXNJackson Financial, Inc. (Michigan) 1.33%28.900.0%$104.73m
EQHEquitable Holdings, Inc. 2.64%33.830.0%$77.56m
EXPIeXp World Holdings, Inc. 1.20%48.980.0%$58.61m
INGING Groep NV 0.89%15.310.2%$49.39m
FOUNUFounder SPAC 0.10%10.020.0%$45.96m
IONQIonQ, Inc. -4.58%10.410.0%$42.22m
LICYLi-Cycle Holdings Corp. -0.13%11.660.0%$38.46m
GGPIGores Guggenheim, Inc. 0.20%10.050.0%$38.14m

Company Profile

Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Greenwich, CT.